News
03-10-2016, 11:30 AM
A drug combination - of lapatinib and trastuzumab (Herceptin) - before surgery shrinks and may even destroy tumours in women with HER2 positive disease within 11 days.
More... (http://www.medicalnewstoday.com/releases/307726.php)
More... (http://www.medicalnewstoday.com/releases/307726.php)